German Cancer Congress (Deutscher Krebskongress)DEUTSCHER KREBSKONGRESS

The German Cancer Congress (Deutscher Krebskongress) is Germany's largest oncology conference. With approximately 500,000 new cancer cases diagnosed annually in Germany, a vast number of patients require treatment. The congress actively fosters interdisciplinary exchange among healthcare professionals, including patient care specialists, researchers, policymakers, and patient advocates. (Copyright belongs to JZhan. Unauthorized reproduction is prohibited.)

A key focus is the rapid translation of medical innovations through research—a crucial driver for oncological progress. For instance, oncologists play a vital role when multidisciplinary tumor boards discuss cases, or when patients transition between inpatient and outpatient care or engage in physician consultations. Moreover, human-machine interaction is becoming increasingly significant in this field. Therefore, addressing interdisciplinary interfaces is one of the most critical issues in oncology, and the German Cancer Congress is proud to tackle this topic head-on.

In recent years, continuous breakthroughs in novel technologies and methodologies in basic and clinical oncology research have led to significant annual advancements in cancer research, diagnosis, and treatment. Regular in-depth discussions and exchanges among academia, clinical practice, industry, and investment sectors are of great significance for further driving innovation in cancer diagnosis and treatment, and accelerating the translation of basic research into clinical and industrial applications. The German Cancer Congress remains committed to flexibly adapting to all developments before and during the event.